Co-expression of somatostatin receptor subtypes and estrogen receptor-α mRNAs by non-functioning pituitary adenomas

Hiroshi Nishioka1, Kazuhiro Tamura, Haruka Iida

  • 1Department of Neurosurgery, Hachioji Medical Center, Tokyo Medical University, Tokyo, Japan. nishioka@tokyo-med.ac.jp

Insights

Non-functioning adenomas (NFomas) show distinct somatostatin receptor (SSTR) and estrogen receptor alpha (ERα) expression. Higher SSTR3 and ERα levels in NFomas suggest their role in adenoma development.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Non-functioning pituitary adenomas (NFomas) are common tumors.
  • The expression patterns of somatostatin receptor (SSTR) subtypes and estrogen receptor alpha (ERα) in NFomas are not well-characterized.
  • Understanding these patterns is crucial for elucidating NFoma pathophysiology.

Purpose of the Study:

  • To investigate the differential expression of SSTR subtypes (1, 2, 3, 5), dopamine receptor (D2R), and ERα in NFomas compared to functioning pituitary adenomas.
  • To explore correlations between SSTR subtypes and ERα expression within NFomas.
  • To identify potential roles of SSTR3 and estrogen in NFoma development.

Main Methods:

  • Real-time quantitative RT-PCR was used to measure mRNA levels.
  • Samples included 59 NFomas, 30 GH-secreting adenomas (GHomas), and 20 prolactinomas (PRLomas).
  • Statistical analysis was performed to compare expression levels and identify correlations.

Main Results:

  • NFomas exhibited higher SSTR3 mRNA levels but lower SSTR2, SSTR5, and D2R mRNA levels compared to functioning adenomas, particularly GHomas.
  • NFomas showed significantly higher ERα mRNA levels than GHomas.
  • SSTR subtype mRNA levels correlated with each other and with ERα in NFomas, especially in patients younger than 50 years.

Conclusions:

  • This study presents the largest analysis to date of SSTR subtype expression in NFomas.
  • Differential expression of SSTR3 and ERα in NFomas suggests their potential involvement in the pathophysiology of these tumors.
  • Age-dependent correlations highlight potential differences in NFoma development pathways.